160 related articles for article (PubMed ID: 8392268)
1. Gonadotropin releasing hormone agonist treatment before hysterectomy for menorrhagia and uterine leiomyomas.
Vercellini P; Bocciolone L; Colombo A; Vendola N; Meschia M; Bolis G
Acta Obstet Gynecol Scand; 1993 Jul; 72(5):369-73. PubMed ID: 8392268
[TBL] [Abstract][Full Text] [Related]
2. Use of goserelin depot, a gonadotropin-releasing hormone agonist, for the treatment of menorrhagia and severe anemia in women with leiomyomata uteri.
Candiani GB; Vercellini P; Fedele L; Arcaini L; Bianchi S; Candiani M
Acta Obstet Gynecol Scand; 1990; 69(5):413-5. PubMed ID: 2148663
[TBL] [Abstract][Full Text] [Related]
3. Goserelin acetate 10.8 mg plus iron versus iron monotherapy prior to surgery in premenopausal women with iron-deficiency anemia due to uterine leiomyomas: results from a Phase III, randomized, multicenter, double-blind, controlled trial.
Muneyyirci-Delale O; Richard-Davis G; Morris T; Armstrong J
Clin Ther; 2007 Aug; 29(8):1682-91. PubMed ID: 17919549
[TBL] [Abstract][Full Text] [Related]
4. GnRH agonists before surgery for uterine leiomyomas. A review.
Crosignani PG; Vercellini P; Meschìa M; Oldani S; Bramante T
J Reprod Med; 1996 Jun; 41(6):415-21. PubMed ID: 8799917
[TBL] [Abstract][Full Text] [Related]
5. Trial of routine gonadotropin releasing hormone agonist treatment before abdominal hysterectomy for leiomyoma.
Balasch J; Manau D; Mimó J; Duran M; Puerto B; Vanrell JA
Acta Obstet Gynecol Scand; 1995 Aug; 74(7):562-5. PubMed ID: 7618457
[TBL] [Abstract][Full Text] [Related]
6. Goserelin acetate to avoid hysterectomy in pre-menopausal women with fibroids requiring surgery.
Parazzini F; Bortolotti A; Chiantera V; Scollo P; Del Monaco D; Bianchi M; Bennici S
Eur J Obstet Gynecol Reprod Biol; 1999 Nov; 87(1):31-3. PubMed ID: 10579613
[TBL] [Abstract][Full Text] [Related]
7. Presurgical treatment of uterine fibroids by using gonadotropin-releasing hormone agonists.
Falsetti L; Mazzani MD; Rubessa S; Ruggeri C
Acta Eur Fertil; 1992; 23(1):29-32. PubMed ID: 1293897
[TBL] [Abstract][Full Text] [Related]
8. Gonadotropin-releasing hormone agonist use before hysterectomy.
Stovall TG; Summit RL; Washburn SA; Ling FW
Am J Obstet Gynecol; 1994 Jun; 170(6):1744-8; discussion 1748-51. PubMed ID: 8203435
[TBL] [Abstract][Full Text] [Related]
9. Treatment with the gonadotrophin releasing hormone-agonist goserelin before hysterectomy for uterine fibroids.
Lumsden MA; West CP; Thomas E; Coutts J; Hillier H; Thomas N; Baird DT
Br J Obstet Gynaecol; 1994 May; 101(5):438-42. PubMed ID: 8018618
[TBL] [Abstract][Full Text] [Related]
10. Corona stenting in a patient menorrhagia: use of a gonadotrophin releasing hormone agonist to facilitate anticoagulation.
Khurana C; Taylor P; de Belder MA
Int J Cardiol; 1998 Jan; 63(1):89-91. PubMed ID: 9482151
[TBL] [Abstract][Full Text] [Related]
11. Goserelin (Zoladex) and the anaemic patient.
Vercellini P; Crosignani PG
Br J Obstet Gynaecol; 1994 May; 101 Suppl 10():33-7. PubMed ID: 8199103
[No Abstract] [Full Text] [Related]
12. Does medical debulking with gonadotrophin-releasing hormone agonist facilitate vaginal hysterectomy with a moderate enlarged uterus? A randomized control study.
Elzaher MA; Moawad A; Madkour WA; Ali M; Salah Eldin Abdel Hamid AM; Zaheer H
Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(2):326-30. PubMed ID: 23537617
[TBL] [Abstract][Full Text] [Related]
13. Uterine volume and menstrual patterns in users of the levonorgestrel-releasing intrauterine system with idiopathic menorrhagia or menorrhagia due to leiomyomas.
Magalhães J; Aldrighi JM; de Lima GR
Contraception; 2007 Mar; 75(3):193-8. PubMed ID: 17303488
[TBL] [Abstract][Full Text] [Related]
14. Guideline No. 389-Medical Management of Symptomatic Uterine Leiomyomas - An Addendum.
Laberge PY; Murji A; Vilos GA; Allaire C; Leyland N; Singh SS
J Obstet Gynaecol Can; 2019 Oct; 41(10):1521-1524. PubMed ID: 31548041
[TBL] [Abstract][Full Text] [Related]
15. Zoladex (goserelin acetate) and the anemic patient: results of a multicenter fibroid study.
Benagiano G; Kivinen ST; Fadini R; Cronjé H; Klintorp S; van der Spuy ZM
Fertil Steril; 1996 Aug; 66(2):223-9. PubMed ID: 8690106
[TBL] [Abstract][Full Text] [Related]
16. Intranasal buserelin versus surgery in the treatment of uterine leiomyomata: long-term follow-up.
Fedele L; Bianchi S; Baglioni A; Arcaini L; Marchini M; Bocciolone L
Eur J Obstet Gynecol Reprod Biol; 1991 Jan; 38(1):53-7. PubMed ID: 1899079
[TBL] [Abstract][Full Text] [Related]
17. Effects on bone mineral density of 12-month goserelin treatment in over 40-year-old women with uterine myomas.
Bianchi S; Fedele L; Vignali M; Galbiati E; Cherubini R; Ortolani S
Calcif Tissue Int; 1995 Jul; 57(1):78-80. PubMed ID: 7671171
[TBL] [Abstract][Full Text] [Related]
18. A randomized trial evaluating leuprolide acetate before hysterectomy as treatment for leiomyomas.
Stovall TG; Ling FW; Henry LC; Woodruff MR
Am J Obstet Gynecol; 1991 Jun; 164(6 Pt 1):1420-3; discussion 1423-5. PubMed ID: 1904681
[TBL] [Abstract][Full Text] [Related]
19. [Methods and efficacy of medical and surgical treatment of non functional menorrhagia].
Brun JL; André G; Descat E; Creux H; Vigier J; Dallay D
J Gynecol Obstet Biol Reprod (Paris); 2008 Dec; 37 Suppl 8():S368-83. PubMed ID: 19268216
[TBL] [Abstract][Full Text] [Related]
20. The effect of levonorgestrel intrauterine system on uterine myomas: a 1-year follow-up study.
Gunes M; Ozdegirmenci O; Kayikcioglu F; Haberal A; Kaplan M
J Minim Invasive Gynecol; 2008; 15(6):735-8. PubMed ID: 18971138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
